Tetrous
SHERMAN OAKS, CA · Manufacturing · 6 employees
Tetrous, Inc. is a regenerative medicine company guided by a team of influential surgeons, and regenerative medicine scientists, and led by experienced Medical Device executives. We utilize next generation advanced technologies for tissue repair in sports medicine with initial focus on improving enthesis repair in rotator cuff repair.
Funding history
- Series seed — $1.7M — Apr 2026
- Series series a — $6.5M — Mar 2025
- Series seed — $445K — Dec 2023
- Series seed — $445K — Dec 2023
Recent signals
- Apr 22, 2026: Raised $1.7M in Series seed
- Mar 24, 2026: Tetrous, Inc. Appoints Thurman Ballard as Vice President of Sales
- Mar 11, 2025: Raised $6.5M in Series series a
- Dec 22, 2023: Raised $445K in Series seed
- Dec 21, 2023: Raised $445K in Series seed
See plans & pricing → Track Tetrous’s funding, hiring, and signals — with verified contacts — on Fundz.